• C
  • L
Aucentra
  • ABOUT US
  • PIPELINE
  • RESEARCH & DEVELOPMENT
    • PUBLICATIONS
  • CLINICAL TRIAL
  • PARTNERS & INVESTORS
  • NEWS & MEDIA
  • JOIN US
  • CONTACT
Select Page

Aucentra initiates its Phase 1a/b study of Auceliciclib in Glioblastoma Multiforme (GBM) patients in combination with Temozolomide

by Aucentra Admin | Feb 25, 2022 | Aucentra News

24 February 2022 Adelaide, Australia- Aucentra Therapeutics is pleased to announce that it has received regulatory approval to progress to a Phase 1a/b clinical trial of Auceliciclib (AU3-14) in combination with Temozolomide for recurrent/refractory GBM patients....

Recent Posts

  • Aucentra Therapeutics appoints Dr Tina Lavranos as Chief Business and Commercialisation Officer
  • Aucentra Therapeutics appoints Dr David Fuller as Chief Medical Officer, commencing 16 November 2022
  • Aucentra Therapeutics appoints Maria Maieli as Chief Financial Officer
  • Prof. Shudong Wang Gives Pancreatic Cancer Research Webinar for UniSA
  • Aucentra Therapeutics Appoints Joe Bayer as Chief Executive Officer

Recent Comments

    Archives

    • August 2023
    • November 2022
    • June 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • November 2021
    • February 2021

    Categories

    • Aucentra News

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
    Privacy & Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    SAVE & ACCEPT